2bind GmbH Opens New Headquarters to as a Result of Quality Work and Continued Growth
January 2024 – 2bind GmbH announces the opening of its new state-of-the-art headquarters in Regensburg. The facility boasts over 1,000 square meters (> 10,000 square feet) of brand-new lab and office spaces, designed to support the company’s expansion in manpower, research services, and in its technology portfolio.
A key highlight of the new headquarters is the dedicated screening lab, equipped to support drug discovery and antibody development with high-throughput biophysical screening assays. The inclusion of a biosafety level 2 (BSL-2) lab enables 2bind to extend its services to clients working with viruses, virus particles, or BSL-2 graded cell lines, further broadening its capabilities in the biophysical research arena. “This new headquarters represents a major milestone for 2bind,” said Dr. Maximilian Plach, COO of 2bind GmbH. “It provides the ideal environment for our expert team of scientists to continue delivering exceptional research services to our clients. With expanded capabilities and state-of-the-art facilities, we are well-positioned to solidify our position as the world’s leading biophysics CRO.”
The investment in this new facility underscores 2bind’s commitment to providing an optimal working environment for the people, fostering innovation, and driving scientific advancements. The company’s continued growth and expansion are a testament to its success in empowering researchers with cutting-edge biophysical solutions.
